Health Care: Drugs

Valeant Pharmaceuticals International Inc (VRX: NYSE)

$117.26 n/a | n/a%
08/22/14 - 04:01 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 5.77B 3.55B 2.46B 1.18B
Cost of Sales 1.70B 944.78M 664.04M 368.63M
Gross Operating Profit 4.07B 2.60B 1.80B 812.60M
Selling, General, and Administrative Expenses 1.54B 812.86M 584.31M 367.42M
Research & Development 156.78M 268.95M 174.89M 157.56M
Operating Income before D & A (EBITDA) 2.37B 1.52B 1.04B 287.63M
Depreciation & Amortization 2.11B 1.02B 620.60M 256.88M
Interest Income 8.02M 5.99M 4.08M 1.29M
Other Income - Net -75.81M -1.24M 21.98M -43.16M
Special Income / Charges -153.64M 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -470.14M 79.17M 315.04M -151.96M
Interest Expense 844.32M 473.40M 333.04M 84.31M
Pre-Tax Income -1.31B -394.23M -18.00M -236.26M
Income Taxes -450.78M -278.20M -177.56M -28.07M
Minority Interest 2.47M 0.00 0.00 0.00
Net Income From Continuing Operations -863.67M -116.02M 159.56M -208.19M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -863.67M -116.02M 159.56M -208.19M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -866.14M -116.02M 159.56M -208.19M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-195.20M 306.97M 290.19M -67.35M
Preferred Dividends
Net Income Available To Common -863.67M -116.02M 159.56M -208.19M
Basic EPS from Continuing Ops. -2.70 -0.38 0.52 -1.06
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -2.70 -0.38 0.52 -1.06
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -2.70 -0.38 0.52 -1.06
Basic Normalized Net Income/Share -0.61 1.01 0.95 -0.34
EPS fr Continuing Ops. -2.70 -0.38 0.49 -1.06
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -2.70 -0.38 0.49 -1.06
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -2.70 -0.38 0.49 -1.06
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.61 1.01 0.89 -0.34
Dividends Paid per Share 0.00 0.00 0.00 1.28

Portfolios with VRX

Latest VRX Headlines from TheStreet

More Financial News for VRX

Press Releases for VRX

See All Press Releases

Partner Headlines for VRX

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter